M. Andrew Wade, SVP and CFO at AtriCure, Inc. (ATRC), sold 1,000 shares at $32.00 ($32K) on 2019-12-26, disclosed to the SEC on 2019-12-30.
Scheduled sale ($32k) by SVP and CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ATRC | SELL | 2020-01-16 | $340K | — | Filing → |
| ATRC | SELL | 2019-11-26 | $351K | — | Filing → |
| ATRC | SELL | 2019-06-06 | $324K | — | Filing → |